These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24354481)

  • 1. Acquired factor XIII deficiency: still a clinical challenge in the era of novel therapy.
    Tha MH; Tien SL
    Haemophilia; 2014 Jan; 20(1):e104-5. PubMed ID: 24354481
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of anti-factor XIII antibodies in a patient with hereditary factor XIII deficiency receiving therapy for chronic hepatitis C.
    Sosa R; Gailani D; Neff AT
    Haemophilia; 2014 Nov; 20(6):e429-32. PubMed ID: 25333572
    [No Abstract]   [Full Text] [Related]  

  • 3. Alloantibodies against the B subunit of plasma factor XIII developed in its congenital deficiency.
    Wada H; Souri M; Matsumoto R; Sugihara T; Ichinose A
    Thromb Haemost; 2013 Apr; 109(4):661-8. PubMed ID: 23407795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune acquired factor XIII deficiency due to anti-factor XIII/13 antibodies: A summary of 93 patients.
    Ichinose A;
    Blood Rev; 2017 Jan; 31(1):37-45. PubMed ID: 27542511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XIII deficiency: pathogenic mechanisms and clinical significance.
    Egbring R; Kröniger A; Seitz R
    Semin Thromb Hemost; 1996; 22(5):419-25. PubMed ID: 8989826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13.
    Osaki T; Sugiyama D; Magari Y; Souri M; Ichinose A
    Thromb Haemost; 2015 Jun; 113(6):1347-56. PubMed ID: 25740658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A patient whose factor XIII level was decreased by double filtrate plasmapheresis and successfully recovered by infusion of factor XIII concentrate.
    Hanafusa N; Aozasa N; Fujita T
    Ther Apher Dial; 2010 Aug; 14(4):432-3. PubMed ID: 20649765
    [No Abstract]   [Full Text] [Related]  

  • 8. [Longtime therapy of congenital factor XIII deficiency using factor XIII concentrate].
    Egbring R; Andrassy K; Havemann K; Fuchs G; Ruf B; Schander K; Trobisch H
    Blut; 1976 Dec; 33(6):367-76. PubMed ID: 1000087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology of Factor XIII and clinical manifestations of Factor XIII deficiency.
    Levy JH; Greenberg C
    Transfusion; 2013 May; 53(5):1120-31. PubMed ID: 22928875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit.
    Tahlan A; Ahluwalia J
    Arch Pathol Lab Med; 2014 Feb; 138(2):278-81. PubMed ID: 24476525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A child with acquired factor XIII deficiency: case report and literature review.
    Kessel R; Hu C; Shore-Lesserson L; Rand J; Manwani D
    Haemophilia; 2013 Nov; 19(6):814-26. PubMed ID: 23607876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XIII deficiency: a differential diagnosis to be considered in suspected nonaccidental injury presenting with intracranial hemorrhage.
    Gordon M; Prakash N; Padmakumar B
    Clin Pediatr (Phila); 2008 May; 47(4):385-7. PubMed ID: 18057145
    [No Abstract]   [Full Text] [Related]  

  • 13. As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan.
    Ichinose A; Souri M;
    Thromb Haemost; 2011 May; 105(5):925-7. PubMed ID: 21264450
    [No Abstract]   [Full Text] [Related]  

  • 14. Report of a patient with chronic intractable autoimmune hemorrhaphilia due to anti-factor XIII/13 antibodies who died of hemorrhage after sustained clinical remission for 3 years.
    Kotake T; Souri M; Takada K; Kosugi S; Nakata S; Ichinose A
    Int J Hematol; 2015 Jun; 101(6):598-602. PubMed ID: 25663511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: Factor XIII concentrate in the long term management of congenital factor XIII deficiency.
    Miloszewski K; Losowsky MS
    Thromb Diath Haemorrh; 1975 Sep; 34(1):323-4. PubMed ID: 810913
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of rituximab in acquired factor XIII inhibitor after arterial rFVIIa-induced thrombosis.
    Ngo Sack F; Galinat H; Egreteau PY; Mollard LM; Fortin H; Berthou C; Abgrall JF; Pan-Petesch B
    Haemophilia; 2013 Mar; 19(2):e93-4. PubMed ID: 23205641
    [No Abstract]   [Full Text] [Related]  

  • 17. [Factor XIII deficiency in adults with acute leukemia: results of a substitution therapy with factor XIII (author's transl)].
    Havemann K; Egbring R; Gropp C; Schmidt M; Sodomann CP
    Klin Wochenschr; 1977 Aug; 55(16):801-9. PubMed ID: 269298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired factor XIII deficiency: a therapeutic challenge.
    Boehlen F; Casini A; Chizzolini C; Mansouri B; Kohler HP; Schroeder V; Reber G; de Moerloose P
    Thromb Haemost; 2013 Mar; 109(3):479-87. PubMed ID: 23306660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with a pasteurised human plasma concentrate in factor XIII deficiency.
    Daly HM; Haddon ME
    Thromb Haemost; 1988 Apr; 59(2):171-4. PubMed ID: 3388293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factor XIII deficiency in burns].
    Burkhardt H; Zellner PR; Möller I
    Chirurg; 1977 Aug; 48(8):520-3. PubMed ID: 902534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.